SBIO
SBIO
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 KYMR | Kymera Therapeutics, Inc. | 4.66% | 70.36K | $6.43M |
 CELC | Celcuity Inc. | 3.34% | 41.24K | $4.61M |
 ALKS | Alkermes plc | 3.21% | 147.17K | $4.43M |
 CGON | CG Oncology, Inc. Common stock | 3.06% | 71.90K | $4.23M |
 MIRM | Mirum Pharmaceuticals, Inc. | 3.06% | 45.80K | $4.23M |
 FOLD | Amicus Therapeutics, Inc. | 2.86% | 274.99K | $3.95M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.68% | 150.79K | $3.70M |
 NAMS | NewAmsterdam Pharma Company N.V. | 2.60% | 101.06K | $3.58M |
 CRNX | Crinetics Pharmaceuticals, Inc. | 2.52% | 84.58K | $3.48M |
 APGE | Apogee Therapeutics, Inc. | 2.48% | 48.87K | $3.42M |
 GPCR | Structure Therapeutics Inc. | 2.47% | 54.08K | $3.41M |
 VKTX | Viking Therapeutics, Inc. | 2.47% | 100.75K | $3.41M |
 XENE | Xenon Pharmaceuticals Inc. | 2.16% | 68.87K | $2.98M |
 SYRE | Spyre Therapeutics, Inc. | 2.15% | 69.16K | $2.97M |
 EWTX | Edgewise Therapeutics, Inc. | 2.08% | 94.36K | $2.87M |
 TARS | Tarsus Pharmaceuticals, Inc. | 2.07% | 37.84K | $2.86M |
 DNLI | Denali Therapeutics Inc. | 2.01% | 131.03K | $2.78M |
 IDYA | IDEAYA Biosciences, Inc. | 1.82% | 78.14K | $2.52M |
 TVTX | Travere Therapeutics, Inc. | 1.72% | 79.74K | $2.38M |
 APLS | Apellis Pharmaceuticals, Inc. | 1.71% | 112.77K | $2.36M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Ireland
Canada
Switzerland
China
Belgium
United Kingdom
GermanySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Ireland Canada Switzerland China Belgium United Kingdom GermanyHoldings (Top 20)
KYMR
Kymera Therapeutics, Inc.
CELC
Celcuity Inc.
ALKS
Alkermes plc
CGON
CG Oncology, Inc. Common stock
MIRM
Mirum Pharmaceuticals, Inc.
FOLD
Amicus Therapeutics, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
NAMS
NewAmsterdam Pharma Company N.V.
CRNX
Crinetics Pharmaceuticals, Inc.
APGE
Apogee Therapeutics, Inc.
GPCR
Structure Therapeutics Inc.
VKTX
Viking Therapeutics, Inc.
XENE
Xenon Pharmaceuticals Inc.
SYRE
Spyre Therapeutics, Inc.
EWTX
Edgewise Therapeutics, Inc.
TARS
Tarsus Pharmaceuticals, Inc.
DNLI
Denali Therapeutics Inc.
IDYA
IDEAYA Biosciences, Inc.
TVTX
Travere Therapeutics, Inc.
APLS
Apellis Pharmaceuticals, Inc.